This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Pasteur, Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique. Active years: 1993-2018.
Company Filing History:
4 out of 897 
3 out of 331 
3 out of 5,383 
Years Active: 1993-2018
Title: Philippe Glaser: Innovator in Molecular Detection
Introduction
Philippe Glaser is a prominent inventor based in Paris, France. He has made significant contributions to the field of molecular detection, particularly in the identification of highly virulent bacterial clones. With a total of 4 patents to his name, Glaser's work has advanced the understanding and detection of infectious agents.
Latest Patents
Glaser's latest patents focus on polynucleotides that enable the rapid, simple, and specific detection of Group B highly virulent ST-17 clones. These inventions also encompass the polypeptides encoded by the polynucleotides, as well as antibodies directed or raised against these polypeptides. Furthermore, his patents include kits and methods for the specific detection of these clones, utilizing the innovative polynucleotides, polypeptides, or antibodies.
Career Highlights
Throughout his career, Philippe Glaser has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in enhancing diagnostic methods and improving public health responses to bacterial infections.
Collaborations
Glaser has collaborated with notable colleagues, including Claire Poyart and Marie-Cécile Lamy. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.
Conclusion
Philippe Glaser's contributions to molecular detection and his innovative patents underscore his role as a leading inventor in the scientific community. His work continues to impact the field of infectious disease detection and management.